Vulnerability Description
An issue was discovered in Telindus Apsal 3.14.2022.235 b. Unauthorized actions that could modify the application behaviour may not be blocked.
CVSS Score
8.4
HIGH
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Telindus | Apsal | 3.14.2022.235_b |
Related Weaknesses (CWE)
References
- https://cds.thalesgroup.com/en/tcs-cert/CVE-2023-26097
- https://excellium-services.com/cert-xlm-advisory/CVE-2023-26097Third Party Advisory
- https://www.telindus.lu/fr/produits/apsalProduct
- https://excellium-services.com/cert-xlm-advisory/CVE-2023-26097Third Party Advisory
- https://www.telindus.lu/fr/produits/apsalProduct
FAQ
What is CVE-2023-26097?
CVE-2023-26097 is a vulnerability with a CVSS score of 8.4 (HIGH). An issue was discovered in Telindus Apsal 3.14.2022.235 b. Unauthorized actions that could modify the application behaviour may not be blocked.
How severe is CVE-2023-26097?
CVE-2023-26097 has been rated HIGH with a CVSS base score of 8.4/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-26097?
Check the references section above for vendor advisories and patch information. Affected products include: Telindus Apsal.